Elbona, 200 mg/ml 2 ml 6 pcs

Pharmaceutical group:

Tissue regeneration stimulator.

Pharmaceutical action:

Elbona is a drug that stimulates the process of cartilage tissue repair.

Glucosamine sulfate has anti-inflammatory and analgesic effect, compensates endogenous glucosamine deficiency, stimulates the synthesis of proteoglycans and hyaluronic acid synovial fluid; promotes sulfur fixation during synthesis of chondroitinic acid, inhibits the development of degenerative processes in joints and restores their function.

Glucosamine helps prevent the destruction of cartilage, stimulates the restoration of cartilage tissue. It improves mobility of joints and reduces the need for NSAIDs.

Indications

Primary and secondary osteoarthritis, spondyloarthritis.

Active ingredient

Composition

Solution A:

2 ml of solution for intramuscular injection contains:

the active ingredient:

glucosamine sulfate sodium chloride 502.5 mg (which corresponds to the content: glucosamine sulfate 400 mg, sodium chloride 102.5 mg).

Auxiliary substances:

tromethamol to pH 2.0-3.0,

lidocaine hydrochloride 10 mg,

water for injection to 2 ml.

Solution B (solvent):

1 ml of the solution contains:

diethanolamine 24 mg,

water for injection to 1 ml.

How to take, the dosage

Intramuscularly! The drug is not intended for intravenous administration.

Before using, mix solution B (solvent) with solution A (drug solution) in one syringe. The prepared solution is administered intramuscularly 3 ml (Solutions A + B) 3 times a week for 4-6 weeks.

Interaction

Compatible with NSAIDs, paracetamol and GCS. Cimetidine and propranolol decrease hepatic clearance of lidocaine (decreased metabolism due to inhibition of microsomal oxidation and decreased hepatic blood flow) and increase the risk of toxic effects.

When prescribed with aymalin, phenytoin, verapamil, quinidine, amiodarone it is possible to increase the negative inotropic effect. Co-administration with beta-adrenoblockers increases the risk of bradycardia. Cardiac glycosides weaken the cardiotonic effect.

The curare-like drugs increase muscle relaxation. Procainamide when used concomitantly with lidocaine increases the risk of CNS agitation and hallucinations.

Concomitant use of hypnotics and sedatives may increase their CNS depressant effects.

In intravenous administration of hexobarbital or sodium thiopental with lidocaine, respiratory depression is possible. Potentiates the effects of MAO inhibitors.

Concomitant use with polymyxin B may increase inhibitory effects on neuromuscular transmission, so in this case it is necessary to monitor the respiratory function of the patient. The effectiveness of hypoglycemic drugs, doxorubicin, teniposide, etoposide may decrease.

Special Instructions

If you are intolerant to seafood (shrimp, shellfish), the likelihood of allergic reactions to Elbona increases.

Contraindications

Individual hypersensitivity to glucosamine, lidocaine hydrochloride and other components of Elbona. Phenylketonuria.
Due to the presence of lidocaine in the drug it is contraindicated when:

With caution:

Side effects

Tolerability of the drug is good.

In some cases it is possible: flatulence, diarrhea, constipation, allergic reactions (urticaria, itching).

Due to the lidocaine content of the drug the following is possible: nausea, vomiting, somnolence, diplopia, headache, dizziness, numbness of the tongue and mucous membrane of the mouth, tremor, euphoria, disorientation, cardiac conduction disorders, anaphylactic reactions.

Similarities